Genmab Announces Net Sales of DARZALEX® ( daratumumab ) for Third Quarter of 2024

4 weeks ago

Company Announcement ...

Ticker	Sentiment	Impact
GMAB	Neutral	59 %
JNJ	Neutral	13 %